ISPC · iSpecimen Inc.

iSpecimen Inc. entered into a securities purchase agreement on May 8, 2026, with accredited investors for a private placement raising approximately $2.5 million in gross proceeds. The offering closed on May 11, 2026, with the issuance of 85,202 shares of common stock at $5.12 per share and 403,088 pre-funded warrants at $5.1199 per warrant (each exercisable for one share of common stock at $0.0001 per share). The pre-funded warrants were offered to investors whose beneficial ownership would otherwise exceed 4.99% of outstanding common stock post-closing. Net proceeds are intended for working capital, including up to $900,000 in marketing expenses. The transaction includes a cap on share issuance of 19.99% of outstanding common stock until stockholder approval is obtained under Nasdaq rules. Additionally, the company regained compliance with Nasdaq's minimum bid price requirement on May 12, 2026, after its closing bid price remained above $1.00 for ten consecutive business days, closing the matter previously disclosed in November 2025. The securities were issued in reliance on exemptions under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.